The effects of chlorotoxin and its derivatives on glioma cells: a systematic review of in vitro studies

References

• Bagley, S.J., et al., 2022. Glioblastoma clinical trials: current landscape and opportunities for improvement. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 28 (4), 594–602.
   PubMed Web of Science ®Google Scholar
• Bastiancich, C., et al., 2021. Rationally designed drug delivery systems for the local treatment of resected glioblastoma. Advanced Drug Delivery Reviews, 177, 113951.
   PubMed Web of Science ®Google Scholar
• Belykh, E., et al., 2020. Blood-brain barrier, blood-brain tumor barrier, and fluorescence-guided neurosurgical oncology: delivering optical labels to brain tumors. Frontiers in Oncology, 10, 739.
   PubMed Web of Science ®Google Scholar
• Chung, S., et al., 2022. Iron Oxide Nanoparticles Decorated with Functional Peptides for a Targeted siRNA Delivery to Glioma Cells. ACS Applied Materials & Interfaces, 15 (1), 106–119.
   PubMed Web of Science ®Google Scholar
• Dardevet, L., et al., 2015. Chlorotoxin: a helpful natural scorpion peptide to diagnose glioma and fight tumor invasion. Toxins, 7 (4), 1079–1101.
   PubMed Web of Science ®Google Scholar
• Dastpeyman, M., et al., 2019. A C-terminal fragment of chlorotoxin retains bioactivity and inhibits cell migration. Frontiers in Pharmacology, 10, 250.
   PubMed Web of Science ®Google Scholar
• Delinois, L.J., et al., 2020. A Cytochrome c‐Chlorotoxin Hybrid Protein as a Possible Antiglioma Drug. ChemMedChem., 15 (22), 2185–2192.
   PubMed Web of Science ®Google Scholar
• Deshane, J., Garner, C.C., and Sontheimer, H., 2003. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. The Journal of Biological Chemistry, 278 (6), 4135–4144.
   PubMed Web of Science ®Google Scholar
• Deb, P. K., et al., 2019. Protein/peptide drug delivery systems: practical considerations in pharmaceutical product development. In Basic Fundamentals of Drug Delivery (pp. 651–684). Amsterdam: Academic Press.
   Google Scholar
• DeBin, J.A., Maggio, J.E., and Strichartz, G.R., 1993. Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. The American Journal of Physiology, 264 (2 Pt 1), C361–C369.
   PubMedGoogle Scholar
• Ding, J., et al., 2014. Scorpion venoms as a potential source of novel cancer therapeutic compounds. Experimental Biology and Medicine (Maywood, N.J.), 239 (4), 387–393.
   PubMed Web of Science ®Google Scholar
• Du, J., et al., 2013. Adenovirus-mediated expression of Bm K CT suppresses growth and invasion of rat C6 glioma cells. Biotechnology Letters, 35 (6), 861–870.
   PubMed Web of Science ®Google Scholar
• Du, J., et al., 2018. BmK CT enhances the sensitivity of temozolomide-induced apoptosis of malignant glioma U251 cells in vitro through blocking the AKT signaling pathway. Oncology Letters, 15 (2), 1537–1544.
   PubMed Web of Science ®Google Scholar
• Fu, Y.J., et al., 2007. Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas. Neuroscience Letters, 412 (1), 62–67.
   PubMed Web of Science ®Google Scholar
• Fu, Y.J., et al., 2011. A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study. Biotechnology Letters, 33 (7), 1309–1317.
   PubMed Web of Science ®Google Scholar
• Fu, Y., et al., 2013. pEGFP-N1-mediated Bm K CT expression suppresses the migration of glioma. Cytotechnology, 65 (4), 533–539.
   PubMed Web of Science ®Google Scholar
• Fu, Y., et al., 2016. Combination of lithium chloride and pEGFP-N1-Bm K CT effectively decreases proliferation and migration of C6 glioma cells. Cytotechnology, 68 (2), 197–202.
   PubMed Web of Science ®Google Scholar
• Graf, N., et al., 2012. Platinum (IV)-chlorotoxin (CTX) conjugates for targeting cancer cells. Journal of Inorganic Biochemistry, 110, 58–63.
   PubMed Web of Science ®Google Scholar
• Kasai, T., et al., 2012. Chlorotoxin fused to IgG-Fc inhibits glioblastoma cell motility via receptor-mediated endocytosis. Journal of Drug Delivery, 2012, 975763–10.
   PubMedGoogle Scholar
• Kesavan, K., et al., 2010. Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. The Journal of Biological Chemistry, 285 (7), 4366–4374.
   PubMed Web of Science ®Google Scholar
• Khanyile, S., et al., 2019. Current biochemical applications and future prospects of chlorotoxin in cancer diagnostics and therapeutics. Advanced Pharmaceutical Bulletin, 9 (4), 510–520.
   PubMed Web of Science ®Google Scholar
• Lui, V.C.H., et al., 2010. Invasion of human glioma cells is regulated by multiple chloride channels including ClC-3. Anticancer Research, 30 (11), 4515–4524.
   PubMed Web of Science ®Google Scholar
• Lyons, S.A., O’Neal, J., and Sontheimer, H., 2002. Chlorotoxin, a scorpion‐derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia, 39 (2), 162–173.
   PubMed Web of Science ®Google Scholar
• Mahajan, S., Schmidt, M.H., and Schumann, U., 2023. The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens. Cancers, 15 (7), 2024.
   PubMed Web of Science ®Google Scholar
• Mamelak, A.N., et al., 2006. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24 (22), 3644–3650.
   PubMed Web of Science ®Google Scholar
• Mcferrin, M.B., and Sontheimer, H., 2006. A role for ion channels in glioma cell invasion. Neuron Glia Biology, 2 (1), 39–49.
   PubMedGoogle Scholar
• Northfield, S.E., et al., 2014. Disulfide-rich macrocyclic peptides as templates in drug design. European Journal of Medicinal Chemistry, 77, 248–257.
   PubMed Web of Science ®Google Scholar
• Page, M.J., Moher, D., and McKenzie, J.E., 2022. Introduction to PRISMA 2020 and implications for research synthesis methodologists. Research Synthesis Methods, 13 (2), 156–163.
   PubMed Web of Science ®Google Scholar
• Park, T., et al., 2019. Genetic engineering and characterisation of chlorotoxin-fused gelonin for enhanced glioblastoma therapy. Journal of Drug Targeting, 27 (9), 950–958.
   PubMed Web of Science ®Google Scholar
• Rjeibi, I., et al., 2011. Purification, synthesis and characterization of AaCtx, the first chlorotoxin-like peptide from Androctonus australis scorpion venom. Peptides, 32 (4), 656–663.
   PubMed Web of Science ®Google Scholar
• Soroceanu, L., et al., 1998. Use of chlorotoxin for targeting of primary brain tumors. Cancer Research, 58 (21), 4871–4879.
   PubMed Web of Science ®Google Scholar
• Soroceanu, L., Manning, T.J., and Sontheimer, H., 1999. Modulation of glioma cell migration and invasion using Cl − and K + ion channel blockers. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 19 (14), 5942–5954.
   PubMed Web of Science ®Google Scholar
• Sun, N., et al., 2017. BmK CT and 125I-BmK CT suppress the invasion of glioma cells in vitro via matrix metalloproteinase-2. Molecular Medicine Reports, 15 (5), 2703–2708.
   PubMed Web of Science ®Google Scholar
• Todo, T., et al., 2022. A phase I/II study of triple-mutated oncolytic herpes virus G47Δ in patients with progressive glioblastoma. Nature Communications, 13 (1), 4119.
   PubMed Web of Science ®Google Scholar
• Turner, K.L., and Sontheimer, H., 2014. Cl − and K + channels and their role in primary brain tumour biology. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 369 (1638), 20130095.
   PubMed Web of Science ®Google Scholar
• van Solinge, T.S., et al., 2022. Advances in local therapy for glioblastoma—taking the fight to the tumour. Nature Reviews. Neurology, 18 (4), 221–236.
   PubMed Web of Science ®Google Scholar
• Vannini, E., et al., 2021. CTX-CNF1 recombinant protein selectively targets glioma cells in vivo. Toxins, 13 (3), 194.
   PubMed Web of Science ®Google Scholar
• Visintin, R., and Ray, S.K., 2022. Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities. Cells, 11 (24), 4063.
   PubMed Web of Science ®Google Scholar
• Wang, X.M., Luo, X., and Guo, Z.Y., 2013. Recombinant expression and downstream processing of the disulfide‑rich tumor‑targeting peptide chlorotoxin. Experimental and Therapeutic Medicine, 6 (4), 1049–1053.
   PubMed Web of Science ®Google Scholar
• Wang, H., et al., 2014. Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug. International Journal of Nanomedicine, 9, 1433–1442.
   PubMed Web of Science ®Google Scholar
• Wen, H., Jung, H., and Li, X., 2015. Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. The AAPS Journal, 17 (6), 1327–1340.
   PubMed Web of Science ®Google Scholar
• Wiranowska, M., Colina, L.O., and Johnson, J.O., 2011. Clathrin-mediated entry and cellular localization of chlorotoxin in human glioma. Cancer Cell International, 11 (1), 27.
   PubMedGoogle Scholar
• Wu, S., et al., 2018. Anti-metastatic effect of 131I-labeled Buthus martensii Karsch chlorotoxin in gliomas. International Journal of Molecular Medicine, 42 (6), 3386–3394.
   PubMed Web of Science ®Google Scholar
• Xu, T., et al., 2016. Identification of two novel Chlorotoxin derivatives CA4 and CTX-23 with chemotherapeutic and anti-angiogenic potential. Scientific Reports, 6 (1), 19799.
   PubMedGoogle Scholar
• Yuan, Z., et al., 2020. Chlorotoxin fusion protein regulates miR-374a and TNFAIP8 expression and inhibits glioma cell proliferation and promotes apoptosis. Cytotechnology, 72 (5), 685–694.
   PubMed Web of Science ®Google Scholar
• Zhao, L., et al., 2019. Chlorotoxin peptide-functionalized polyethylenimine-entrapped gold nanoparticles for glioma SPECT/CT imaging and radionuclide therapy. Journal of Nanobiotechnology, 17 (1), 30.
   PubMedGoogle Scholar
• Zhai, H., et al., 2011. Annexin A2 promotes glioma cell invasion and tumor progression. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 31 (40), 14346–14360.
   PubMed Web of Science ®Google Scholar